InvestorsHub Logo
Followers 16
Posts 672
Boards Moderated 0
Alias Born 01/06/2017

Re: Virgilio post# 139837

Saturday, 10/21/2017 2:00:38 PM

Saturday, October 21, 2017 2:00:38 PM

Post# of 682060
Actually it's quite positive for the trial (though not positive for patients unfortunately) as it is an explanation as to why dcvaxl alone doesn't work particularly well for rGBM...I.e. progressing SOC patients in the current p3 that elect to switch to dcvaxl...If he's right then the likelihood of crossover confoundment is low...It'll help give a clearer distinction between the test and control curves and a better pvalue
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News